https://covaxx.reportablenews.com daily 1.0 https://covaxx.reportablenews.com/pr/covaxx-s-covid-19-vaccine-ub-612-induced-neutralizing-antibodies-in-100-of-participants-during-phase-1-clinical-trial 2021-02-08T08:00:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-announces-initiation-of-phase-2-clinical-trials-in-taiwan-of-ub-612-vaccine-candidate-against-covid-19 2021-02-02T09:00:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-announces-early-design-and-testing-of-new-vaccine-candidate-to-address-mutations-in-sars-cov-2 2021-01-08T08:00:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-and-aurobindo-pharma-announce-covid-19-vaccine-partnership 2020-12-24T08:00:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-vaccine-prioritization-advisory-group-provides-guidelines-for-equitable-deployment-of-covid-19-vaccine-doses-to-emerging-countries 2020-12-23T08:00:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-to-participate-in-opening-keynote-panel-with-fda-and-who-experts-on-sars-cov-2-at-the-world-vaccine-immunotherapy-conference-west-coast-december-1-2020 2020-11-30T09:00:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-to-deliver-2-8-billion-in-vaccine-advance-purchase-commitments-110-million-doses-to-emerging-countries 2020-11-25T08:45:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-and-maersk-enter-partnership-to-supply-covid-19-vaccines-globally 2020-10-22T13:30:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-to-present-data-on-covid-19-vaccine-candidate-ub-612-at-two-virtual-scientific-conferences 2020-10-20T07:00:00Z monthly 0.5 https://covaxx.reportablenews.com/pr/covaxx-initiates-phase-1-clinical-trial-of-covid-19-vaccine-ub-612-in-taiwan 2020-09-28T00:00:00Z monthly 0.5